Planned C-sections can increase your child's risk of these serious conditions
Planned C-sections allow doctors and expecting moms to sidestep some of the unpredictability of labor and offer an attractive amount of convenience and, for some, more peace of mind.
But a new study out of Sweden is raising some red flags about what comes later for your bundle of joy.
Advertisement
3 A new study out of Sweden is raising some red flags about post-cesarean life for your baby.
Charlie's – stock.adobe.com
Researchers analyzed the data of nearly 2.5 million children born between 1982 to 1989 and 1999 to 2015 and found that that babies delivered via C-section were more likely to develop certain cancers than those delivered vaginally.
Of the nearly 376,000 children who were born using this method, 1,495 later developed leukemia — and those who were delivered by planned C-section, versus emergency, were at higher risk.
Advertisement
Specifically, the C-section babies had a 21% higher risk of acute lymphoblastic leukemia (ALL) — the most common type in children — and a 29% increased risk of B-cell acute lymphoblastic leukemia (B-ALL) — its most common subtype.
Experts believe the heightened risk may stem from how a planned C-section circumvents natural physiological processes triggered during labor — like the release of important hormones as well as exposure to beneficial bacteria — which may play a role in protecting against certain diseases later in life.
Crucially, the increased risk was not observed in emergency cesarean sections, which typically occur after labor has already started.
Researchers note that the overall risk of these diseases is low.
Advertisement
3 In the US, C-sections account for as much as 32% of all births.
íí½í½í° íâíâ¬íÆíí½í¸íâ íâ¹í½í° – stock.adobe.com
'Fortunately, ALL is rare. This means that many C-deliveries are needed to obtain a statistically significant result, and it is difficult to obtain such a large sample in a Swedish registry study,' Christina-Evmorfia Kampitsi, a researcher at the Institute of Environmental Medicine, Karolinska Institutet in Stockholm, said in a press release.
'However, the results are close to significant, are in line with what previous studies have shown, and remain when we adjust for other relevant factors, which still makes them relevant.'
Advertisement
Additionally, the researchers point out that the percentage of C-section births in Sweden is only 11-15% and the overall childhood leukemia rate is roughly 4.5 per 100,000.
In the US, C-sections account for as much as 32% of all births and childhood leukemia occurs at a slightly higher rate of about 5.6 per 100,000 children.
3 'C-sections are an important and often life-saving part of obstetric care. We don't want mothers to feel anxious about medically indicated C-sections,' Kampitsi said.
Martin Valigursky – stock.adobe.com
The findings were published Friday in the International Journal of Cancer.
Kampitsi urged expecting mothers not to write off C-sections entirely — however, it might be worth discussing alternatives with your doctor, given the link between C-sections and other conditions.
'C-sections are an important and often life-saving part of obstetric care. We don't want mothers to feel anxious about medically indicated C-sections,' Kampitsi said.
But Kampitsi points to other studies that have shown planned C-sections also increase the risk of other conditions, including asthma, allergies and Type 1 diabetes.
Advertisement
A 2024 meta-analysis, for one, suggests that C-section births increase the risk of food allergies by 35% and asthma by 20% in children later in life.
And a 2011 meta-analysis found that C-sections lead to a 20% increased risk of Type 1 diabetes in kids.
'There is reason to discuss C-sections that are not medically indicated,' she added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
2 days ago
- New York Post
Baby girl grows ‘micropenis' after laying on her dad's chest
A baby girl in Sweden reportedly sprouted a 'micropenis' after lying on her father's bare chest — turning a tender bonding moment into a bizarre biological blunder. And she's not the only one. A Swedish doctor is sounding the alarm, warning she's seen at least half a dozen similar cases in children. Here's what you need to know to make sure your child isn't next. 4 Skin-to-skin contact can help regulate the baby's body temperature, heart rate and breathing. barneyboogles – Often referred to as 'kangaroo care,' skin-to-skin contact is a common practice used to strengthen the bond between newborns and parents while supporting healthy early development. But in this case, that sweet ritual took a strange turn. After her birth, the Swedish baby girl was repeatedly placed on her father's bare chest — the same area where he had applied testosterone gel. The topical medication is commonly prescribed to men with hypogonadism, a condition in which the body doesn't produce enough sex hormones. It's more common than you might think. Research suggests that, after the age of 40, men's testosterone levels fall by about 1% each year, a biological process sometimes colloquially called 'manopause.' While hypogonadism can affect men of any age, studies suggest that roughly 40% of those over 45 and half of men in their 80s have clinically low testosterone. 4 Testosterone gel increases levels of the testosterone hormone in your body. mbruxelle – Over time, this drop can lead to a range of symptoms, including low sex drive, erectile dysfunction, fatigue, mood swings and muscle loss — issues that testosterone replacement therapy (TRT) can help treat. Unaware of the risk, the father's skin-to-skin contact inadvertently exposed his daughter to high levels of testosterone — triggering dramatic changes in her genitalia. Her parents noticed that her clitoris had begun to elongate, resembling a small penis, while her labia began to fuse, eventually looking similar to a male scrotum. Panicked, they brought their 10-month-old daughter to a doctor. Blood tests quickly identified the source. 4 Secondary exposure to testosterone gel in children can trigger adverse effects such as premature puberty. – 'I don't think people always understand how potent these treatments are,' Professor Jovanna Dahlgren, a pediatric endocrinologist at Sahlgrenska University Hospital, told local news outlet Göteborgs-Posten. 'The parents become completely desperate when they understand what has happened,' she added. The case, which occurred eight years ago, is one of at least six similar incidents Dahlgren has seen, all involving young children unintentionally exposed to hormone medication through close contact with a parent. In one case, she said, a 10-year-old boy developed breasts after coming into contact with estrogen cream his mother had been using. Fortunately, in the Swedish girl's case, her genitals began to shrink once her father stopped using the gel and the accidental exposure ceased. And while local media described the case as a 'micropenis,' experts note that's not technically accurate, as the term refers specifically to underdeveloped male genitalia — not virilized female anatomy. 4 Testosterone decline in men, common with age, can lead to side effects like erectile dysfunction. Kaspars Grinvalds – The story comes amid a surge in TRT popularity, including in the US, where prescriptions jumped from 7.3 million in 2019 to over 11 million last year, according to CBS News. High-profile names like Josh Duhamel, Sylvester Stallone, Joe Rogan — and even Health and Human Services Secretary Robert F. Kennedy Jr. — have gotten in on the hormone hack. But it's not just aging men fueling the trend. On TikTok, the hashtag 'TRT Before and After' has exploded with millions of views, showcasing ripped guys in their 20s and 30s boasting about about boosted energy levels and sex drives. Experts, however, warn TRT isn't without risks. Side effects can include acne, fluid retention, testicular shrinkage, reduced fertility and worsened sleep apnea, according to the Cleveland Clinic. TRT comes in several forms: pills, injections, patches, and gels. If you use the topical gel, the Mayo Clinic advises washing your hands thoroughly after application and rinsing the treated area before any skin-to-skin contact to avoid accidentally exposing others.
Medscape
2 days ago
- Medscape
Frequent Walking Tied to Lower CVD Risk in Seniors Above 80
TOPLINE: In older adults initially free of cardiovascular disease (CVD), each additional 10 moderate-to-vigorous physical activity walking events was associated with a reduced risk for CVD. In those aged 80 years or older, frequent light physical activity walking bouts also provided significant protection. METHODOLOGY: Moderate-to-vigorous physical activity (three or more metabolic equivalents) has been known to reduce the risk for CVD in older adults; however, the influence of different activity patterns and age-related differences remain unclear. Researchers analysed data from a Swedish cohort study and included 423 participants aged either 66 years or 80 years or older (67.4% women) without any CVD. Thigh-worn accelerometers were used to measure physical activity such as steps per day, sit-to-stand transitions, daily time in light and moderate-to-vigorous physical activity, and walking events. Walking events were identified as continuous walking bouts (excluding standing), with less than 100 steps per minute being classified as light and 100 or more steps per minute being classified as moderate-to-vigorous physical activity. The primary outcome was the incidence of both fatal and non-fatal CVD events, tracked over a mean follow-up duration of 5.6 years. TAKEAWAY: The participants took an average of 9276 steps per day and engaged in 35.5 minutes of moderate-to-vigorous physical activity per day; 30% of participants experienced at least one CVD event during the follow-up period. Overall, each additional 10 moderate-to-vigorous physical activity walking events was associated with a 10% reduced risk for CVD (adjusted hazard ratio, 0.90; P = .019). Among participants aged 80 years or older, the risk for CVD reduced by 39% for each additional 100 light physical activity walking events and by 13% for each additional 10 moderate-to-vigorous physical activity walking events (P < .05 for both). No clear associations between physical activity patterns and the risk for CVD were observed among younger-old adults (66 years). IN PRACTICE: "Our findings suggest that the daily frequency of PA [physical activity] events, alongside adherence to international MVPA [moderate-to-vigorous PA] recommendations (≥ 150-300 minutes per week), may offer added benefits in mitigating CVD risk," the authors wrote. SOURCE: This study was led by Caroline Lager, PhD student, Karolinska Institutet, Stockholm, Sweden. It was published online on July 12, 2025, in the European Journal of Preventive Cardiology. LIMITATIONS: Accelerometers may not have provided accurate measures of activities such as cycling, resistance training, or water-based exercises. Intensity levels of activities may have been misclassified. Data on physical activity may have been incomplete as the accelerometers were worn only during waking hours. DISCLOSURES: This study received support from the Swedish Research Council, the Swedish Ministry of Health and Social Affairs, and participating county councils and municipalities. Additional support was provided by The Mälardalen area doctoral school in health care science and the Strategic Research Area Health Care Science at Karolinska Institutet. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
2 days ago
- Yahoo
AstraZeneca pledges $50bn investment in the US amid 200% tariff fears
AstraZeneca will invest $50 billion (€42.8 bn) in the US by 2030 in a move to expand its R&D and manufacturing there, the firm announced on Monday. This comes as the pharmaceutical giant aims to reach the target of $80 billion (€68.5 bn) in revenue by 2030, with 50% of it hoped to come from the US. The announcement also comes as the Trump administration threatens tariffs of up to 200% on drugs that are produced outside of the US. The new investment announcement is in addition to the $3.5 billion (€3 bn) pledged in November 2024. According to a statement from the company, the US plays a 'critical role' in AstraZeneca's ability 'to launch 20 new medicines by the end of the decade'. What will AstraZeneca produce in the US? As part of the investment, the British-Swedish company plans to build a new multi-billion dollar manufacturing facility in the state of Virginia. This plant will focus on the production of treatments for chronic diseases and is the largest single investment into a facility the company has ever made. '[This] announcement underpins our belief in America's innovation in biopharmaceuticals and our commitment to the millions of patients who need our medicines in America and globally,' Pascal Soriot, Chief Executive Officer at AstraZeneca said in a statement from the company. 'I look forward to partnering with Governor Youngkin and his team to work on our largest single manufacturing investment ever. It reflects the Commonwealth of Virginia's desire to create highly skilled jobs in science and technology, and will strengthen the country's domestic supply chain for medicines.' Related Revolut to create 400 new jobs as Paris HQ leads hopes towards French banking licence Universal Music Group confidentially files for US stock market listing The site in Virginia will have a particular focus on producing substances which make up AstraZeneca's weight management and metabolic treatment portfolio. As well as the site in Virginia, the investment will help expand facilities and production in Massachusetts, Maryland, California, Indiana and Texas, as well as finding new sites for clinical trials. AstraZeneca already has 19 R&D, manufacturing and commercial sites in the US, and the country is the company's largest market, representing 42% of their revenue. The firm currently employs more than 18,000 people and supports 92,000 jobs across the US. The new investment announcement is expected to create tens of thousands more jobs in the coming years. Howard Lutnick, US Secretary of Commerce, said: 'For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness. We are proud that AstraZeneca has made the decision to bring substantial pharmaceutical production to our shores. This historic investment is bringing tens of thousands of jobs to the US and will ensure medicine sold in our country is produced right here.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
